Kim Jong-Min, Sim Jae-Ang, Yang HongYeol, Kim Young-Mo, Wang Joon-Ho, Seon Jong-Keun
Department of Orthopaedic Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Department of Orthopaedic Surgery, Gil Hospital, Gachon University of Medicine and Science, Incheon, Republic of Korea.
Am J Sports Med. 2021 Oct;49(12):3335-3343. doi: 10.1177/03635465211037716. Epub 2021 Sep 8.
No clear guidelines or widespread consensus has defined a threshold value of tibial tuberosity-trochlear groove (TT-TG) distance for choosing the appropriate surgical procedures when additional tibial tuberosity osteotomy (TTO) should be added to augment medial patellofemoral ligament (MPFL) reconstruction for recurrent patellar instability.
To compare the clinical outcomes between MPFL reconstruction and MPFL reconstruction with TTO for patients who have patellar instability with a TT-TG distance of 15 to 25 mm.
Cohort study; Level of evidence, 3.
We retrospectively analyzed 81 patients who underwent surgical treatment using either MPFL reconstruction or MPFL reconstruction with TTO for recurrent patellar instability with a TT-TG distance of 15 to 25 mm; the mean follow-up was 25.2 months (range, 12.0-53.0 months). The patients were divided into 2 groups: isolated MPFL reconstruction (iMPFL group; n = 36) performed by 2 surgeons and MPFL reconstruction with TTO (TTO group; n = 45) performed by another 2 surgeons. Clinical outcomes were assessed using the Kujala score, Knee injury and Osteoarthritis Outcome Score, and Tegner activity score. Radiological parameters, including patellar height, TT-TG distance, patellar tilt, and congruence angle were compared between the 2 groups. Functional failure based on clinical apprehension sign, repeat subluxation or dislocation, and subjective instability and complications was assessed at the final follow-up. We also compared clinical outcomes based on subgroups of preoperative TT-TG distance (15 mm ≤ TT-TG ≤ 20 mm vs 20 mm < TT-TG ≤ 25 mm).
All of the clinical outcome parameters significantly improved in both groups at the final follow-up ( < .001), with no significant differences between groups. The radiological parameters also showed no significant differences between the 2 groups. The incidence of functional failure was similar between the 2 groups (3 failures in the TTO group and 2 failures in the iMPFL group; = .42). In the TTO group, 1 patient experienced a repeat dislocation postoperatively and 2 patients had subjective instability; in the iMPFL group, 2 patients had subjective instability. The prevalence of complications did not differ between the 2 groups ( = .410). In the subgroup analysis based on TT-TG distance, we did not note any differences in clinical outcomes between iMPFL and TTO groups in subgroups of 15 mm ≤ TT-TG ≤ 20 mm and 20 mm < TT-TG ≤ 25 mm.
MPFL reconstruction with and without TTO provided similar, satisfactory clinical outcomes and low redislocation rates for patients who had patellar instability with a TT-TG distance of 15 to 25 mm, without statistical difference. Thus, our findings suggest that iMPFL reconstruction is a safe and reliable treatment for patients with recurrent patellar dislocation with a TT-TG distance of 15 to 25 mm, without the disadvantages derived from TTO.
当为复发性髌骨不稳定患者进行内侧髌股韧带(MPFL)重建时,若需额外增加胫骨结节截骨术(TTO)以增强手术效果,目前尚无明确的指南或广泛共识来界定胫骨结节 - 滑车沟(TT - TG)距离的阈值,以指导选择合适的手术方式。
比较TT - TG距离在15至25mm之间的髌骨不稳定患者,单纯MPFL重建与MPFL重建联合TTO的临床疗效。
队列研究;证据等级,3级。
我们回顾性分析了81例因复发性髌骨不稳定且TT - TG距离在15至25mm之间而接受手术治疗的患者,这些患者分别接受了单纯MPFL重建(iMPFL组;n = 36)或MPFL重建联合TTO(TTO组;n = 45)。手术分别由两组不同的外科医生进行,平均随访时间为25.2个月(范围12.0 - 53.0个月)。使用Kujala评分、膝关节损伤和骨关节炎疗效评分以及Tegner活动评分评估临床疗效。比较两组间的影像学参数,包括髌骨高度、TT - TG距离、髌骨倾斜度和适合角。在末次随访时评估基于临床恐惧征、复发性半脱位或脱位、主观不稳定感和并发症的功能失败情况。我们还根据术前TT - TG距离的亚组(15mm≤TT - TG≤20mm与20mm < TT - TG≤25mm)比较了临床疗效。
两组在末次随访时所有临床疗效参数均显著改善(P <.001),组间无显著差异。影像学参数在两组间也无显著差异。两组的功能失败发生率相似(TTO组3例失败,iMPFL组2例失败;P = 0.42)。在TTO组,1例患者术后出现复发性脱位,2例患者有主观不稳定感;在iMPFL组,2例患者有主观不稳定感。两组并发症的发生率无差异(P = 0.410)。在基于TT - TG距离的亚组分析中,我们未发现iMPFL组和TTO组在15mm≤TT - TG≤了20mm和20mm < TT - TG≤25mm亚组的临床疗效有任何差异。
对于TT - TG距离在15至25mm之间的髌骨不稳定患者,MPFL重建联合或不联合TTO均能提供相似且令人满意的临床疗效和低再脱位率,无统计学差异。因此,我们的研究结果表明,对于TT - TG距离在15至25mm之间的复发性髌骨脱位患者,单纯MPFL重建是一种安全可靠的治疗方法,且没有TTO带来的弊端。